{"data":{"matter":{"matter_id":"mat_5c445c740078a1","slug":"suboxone-tooth-decay","name":"Suboxone Tooth Decay / Dental Injury MDL","category":"mass_tort","subcategory":"pharma","status":"litigated","score":0.74,"score_30d":0.474,"velocity":0.1765,"headline":"Suboxone tooth decay and dental injury MDL - newly consolidated","summary":"Indivior's Suboxone sublingual films have been alleged to cause severe tooth decay, dental erosion, and tooth loss due to extended oral contact with the medication's acidic compounds. MDL No. 3092 was consolidated in the Northern District of Ohio in 2024. Suboxone is used for opioid use disorder treatment, so plaintiffs are typically long-term medication-assisted treatment patients.","eligibility_hint":"Used Suboxone sublingual films for at least six months and experienced severe tooth decay, dental erosion, or tooth loss","payout":{"band":"mass_tort","low_cents":500000,"high_cents":15000000,"low_usd":5000,"high_usd":150000},"keywords":{"products":["suboxone","buprenorphine","naloxone","sublingual film"],"brands":["indivior","reckitt benckiser"]},"links":{"primary":"https://www.ohnd.uscourts.gov/","self":"https://getclaimscout.com/api/v1/matters/suboxone-tooth-decay","html":"https://getclaimscout.com/matters/suboxone-tooth-decay","lp":null},"lifecycle":{"first_seen_iso":"2026-05-19T11:12:27Z","last_signal_iso":"2026-10-17T10:42:11Z","mdl_filed_iso":null,"settlement_announced_iso":null,"claims_open_iso":null,"claims_close_iso":null,"narrative_generated_iso":"2026-07-07T10:06:25Z"},"attached_cases_count":0,"embedding_model":null,"embedding_version":1,"schema_version":1},"attached_cases":[],"recent_signals":[{"signal_id":"sig_443347e3543a02","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:74782767","kind":"court_filing","title":"CL filing: Fas-Tes Franchise Systems, LLC v. Ramsey Diagnostics Corp.","summary":"Federal filing in vaed, docket 2:26-cv-00961, dated 2026-09-11.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"vaed","docket_no":"2:26-cv-00961","date_filed":"2026-09-11","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-10-18T10:58:15Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-10-17T10:42:11Z","last_seen_iso":"2026-10-18T10:58:15Z","schema_version":1},{"signal_id":"sig_1680f7329f33fe","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:74737949","kind":"court_filing","title":"CL filing: Billy F. Steffey v. United States of America","summary":"Federal filing in cacd, docket 2:26-cv-09497, dated 2026-08-19.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"cacd","docket_no":"2:26-cv-09497","date_filed":"2026-08-19","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-10-18T10:58:15Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-10-15T11:24:39Z","last_seen_iso":"2026-10-18T10:58:15Z","schema_version":1},{"signal_id":"sig_1264eece5a777f","matter_id":"mat_5c445c740078a1","source":"regulations_gov","source_id":"reggov:DEA-2026-1190-0006","kind":"regulations_doc","title":"Schedules of Controlled Substances: Temporary Placement of 7- Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I","summary":"","url":"https://www.regulations.gov/document/DEA-2026-1190-0006","score":0.5,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Proposed Rule","file_url":null,"agency_id":"DEA","source_url":"https://www.regulations.gov/document/DEA-2026-1190-0006","posted_date":"2026-10-14T04:00:00Z","retrieved_at":"2026-10-18T10:50:48Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-10-15T11:16:46Z","last_seen_iso":"2026-10-18T10:50:48Z","schema_version":1},{"signal_id":"sig_cbe889102e0d10","matter_id":"mat_5c445c740078a1","source":"regulations_gov","source_id":"reggov:DEA-2026-1190-0005","kind":"regulations_doc","title":"261008 ASH memo to DEA- Recommendation on 7-OH thresholding- 712892 ASH signed- UPDATED","summary":"","url":"https://www.regulations.gov/document/DEA-2026-1190-0005","score":0.5,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Supporting & Related Material","file_url":null,"agency_id":"DEA","source_url":"https://www.regulations.gov/document/DEA-2026-1190-0005","posted_date":"2026-10-13T04:00:00Z","retrieved_at":"2026-10-18T10:50:48Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-10-14T11:40:33Z","last_seen_iso":"2026-10-18T10:50:48Z","schema_version":1},{"signal_id":"sig_779ee62715ca88","matter_id":"mat_5c445c740078a1","source":"google_news","source_id":"gnews:CBMikwFBVV95cUxNdmh4OF9SZDd6bmZZZzF6cVZpYWJkTy1XZDJiakpHVWJWT1FGOTBycUFTUG9yYlVOUjNnQWZMZ0xpV2lwZGFEOVNvYkpaMDlEdXNHekpvLWROU3JMc1lMTGNzOG5zQXpWeHhNX0xRZ3BXUXhVME10Y0lpLXRXek1oWlJyYnNoUENtWnpFWDhsTm1Jb1E","kind":"news_article","title":"Ban on Suboxone use for ‘safety-sensitive’ roles draws EEOC lawsuit - Yahoo","summary":"Ban on Suboxone use for ‘safety-sensitive’ roles draws EEOC lawsuit    Yahoo","url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNdmh4OF9SZDd6bmZZZzF6cVZpYWJkTy1XZDJiakpHVWJWT1FGOTBycUFTUG9yYlVOUjNnQWZMZ0xpV2lwZGFEOVNvYkpaMDlEdXNHekpvLWROU3JMc1lMTGNzOG5zQXpWeHhNX0xRZ3BXUXhVME10Y0lpLXRXek1oWlJyYnNoUENtWnpFWDhsTm1Jb1E?oc=5","score":0.55,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"google_news_rss","published":"Thu, 01 Oct 2026 07:00:00 GMT","source_url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNdmh4OF9SZDd6bmZZZzF6cVZpYWJkTy1XZDJiakpHVWJWT1FGOTBycUFTUG9yYlVOUjNnQWZMZ0xpV2lwZGFEOVNvYkpaMDlEdXNHekpvLWROU3JMc1lMTGNzOG5zQXpWeHhNX0xRZ3BXUXhVME10Y0lpLXRXek1oWlJyYnNoUENtWnpFWDhsTm1Jb1E?oc=5","retrieved_at":"2026-10-17T10:33:07Z","search_query":"\"suboxone\" (lawsuit OR settlement OR recall OR \"class action\")"},"resolved_by":"auto","resolution_confidence":0.875,"first_seen_iso":"2026-10-14T11:39:22Z","last_seen_iso":"2026-10-17T10:33:07Z","schema_version":1},{"signal_id":"sig_dd84b65175f914","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:74942409","kind":"court_filing","title":"CL filing: AMERICAN HOSPITAL ASSOCIATION v. KENNEDY","summary":"Federal filing in med, docket 1:26-cv-00515, dated 2026-10-09.","url":"https://www.courtlistener.com/recap/?q=ozempic","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"med","docket_no":"1:26-cv-00515","date_filed":"2026-10-09","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-10-18T10:58:15Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-10-10T12:25:19Z","last_seen_iso":"2026-10-18T10:58:15Z","schema_version":1},{"signal_id":"sig_e0c4ddb49defc8","matter_id":"mat_5c445c740078a1","source":"regulations_gov","source_id":"reggov:FDA-2026-N-10429-0006","kind":"regulations_doc","title":"Reference 5 - Kock, P., Froelich, K., Walter, M., Lang, U., and K.M. Du¨ rsteler, ‘‘A systematic literature review of clinical trials and therapeutic applications of ibogaine,’’ J. Subst. Abuse Treat., 138:108717 (2022), available at doi:10.1016/j.jsat.2021.108717.","summary":"Background Material","url":"https://www.regulations.gov/document/FDA-2026-N-10429-0006","score":0.5,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Supporting & Related Material","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2026-N-10429-0006","posted_date":"2026-10-06T04:00:00Z","retrieved_at":"2026-10-18T10:50:48Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-10-07T13:07:58Z","last_seen_iso":"2026-10-18T10:50:48Z","schema_version":1},{"signal_id":"sig_825d749f783023","matter_id":"mat_5c445c740078a1","source":"regulations_gov","source_id":"reggov:FDA-2026-N-10429-0002","kind":"regulations_doc","title":"Reference 1 - Alper, K.R., Stajic´, M., and J.R. Gill, ‘‘Fatalities temporally associated with the ingestion of ibogaine,’’ J. Forensic Sci., 57(2):398–412 (2012), available at doi:10.1111/j.1556-4029.2011.02008.x.","summary":"Background Material","url":"https://www.regulations.gov/document/FDA-2026-N-10429-0002","score":0.5,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Supporting & Related Material","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2026-N-10429-0002","posted_date":"2026-10-06T04:00:00Z","retrieved_at":"2026-10-18T10:50:48Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-10-07T13:07:58Z","last_seen_iso":"2026-10-18T10:50:48Z","schema_version":1},{"signal_id":"sig_79c3d4b84c67d6","matter_id":"mat_5c445c740078a1","source":"regulations_gov","source_id":"reggov:FDA-2026-N-10429-0004","kind":"regulations_doc","title":"Reference 3 - Knuijver, T., Schellekens, A., Belgers, M., Donders, R., van Oosteren, T., et al., ‘‘Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study,’’ Addiction, 117(1):118–128 (2022), available at doi:10.1111/add.15448","summary":"Background Material","url":"https://www.regulations.gov/document/FDA-2026-N-10429-0004","score":0.5,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Supporting & Related Material","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2026-N-10429-0004","posted_date":"2026-10-06T04:00:00Z","retrieved_at":"2026-10-18T10:50:48Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-10-07T13:07:58Z","last_seen_iso":"2026-10-18T10:50:48Z","schema_version":1},{"signal_id":"sig_95c47225319d07","matter_id":"mat_5c445c740078a1","source":"regulations_gov","source_id":"reggov:FDA-2026-N-10429-0005","kind":"regulations_doc","title":"Reference 4 - Knuijver, T., ter Heine, R., Schellekens, A.F.A., Heydari, P., Lucas, L., et al., ‘‘The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients,’’ J. Psychopharmacol., 38(5):481–488 (2024),\navailable at doi:10.1177/02698811241237873.","summary":"Background Material","url":"https://www.regulations.gov/document/FDA-2026-N-10429-0005","score":0.5,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Supporting & Related Material","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2026-N-10429-0005","posted_date":"2026-10-06T04:00:00Z","retrieved_at":"2026-10-18T10:50:48Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-10-07T13:07:58Z","last_seen_iso":"2026-10-18T10:50:48Z","schema_version":1},{"signal_id":"sig_4f9ca3b38449a5","matter_id":"mat_5c445c740078a1","source":"regulations_gov","source_id":"reggov:FDA-2026-N-10429-0001","kind":"regulations_doc","title":"Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for Information","summary":"Requests for Information (RFI)","url":"https://www.regulations.gov/document/FDA-2026-N-10429-0001","score":0.5,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Notice","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2026-N-10429-0001","posted_date":"2026-10-06T04:00:00Z","retrieved_at":"2026-10-18T10:50:48Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-10-07T13:07:58Z","last_seen_iso":"2026-10-18T10:50:48Z","schema_version":1},{"signal_id":"sig_61c6e4539eb0dd","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:74826272","kind":"court_filing","title":"CL filing: Smith v. Jefferson County","summary":"Federal filing in tned, docket 1:26-cv-00269, dated 2026-09-21.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"tned","docket_no":"1:26-cv-00269","date_filed":"2026-09-21","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-10-18T10:58:15Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-10-03T11:41:09Z","last_seen_iso":"2026-10-18T10:58:15Z","schema_version":1},{"signal_id":"sig_964d5ee66799eb","matter_id":"mat_5c445c740078a1","source":"google_news","source_id":"gnews:CBMiywFBVV95cUxQUk40RWRJc3VxZ2xmVlR3YU4yY3VYdXZ2NXdBVmFJbl83bmVoSUl6V2RXVjJWSUJxWUVMczVvSFFqRGNOc29RU3dFdWN4ZFNxMjU4Wlp3eXJ0QS0tSFhpVUFwU3o5YTJkUGZYaWFrUDRVbHRqN2ZvbXJfM2tCX1NhRU1ZM0Q3Z29hbTE2UjBRRTdxRC11bm5IRDNibUtxbWJPZVBhZVg5YWpESlAyYXdKQy1FeGVENkE5dU5LREFyNExDWExTLVRXZE52dw","kind":"news_article","title":"Could Antitrust Law Have Saved Your Teeth? - LawyersandSettlements.com","summary":"Could Antitrust Law Have Saved Your Teeth?    LawyersandSettlements.com","url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQUk40RWRJc3VxZ2xmVlR3YU4yY3VYdXZ2NXdBVmFJbl83bmVoSUl6V2RXVjJWSUJxWUVMczVvSFFqRGNOc29RU3dFdWN4ZFNxMjU4Wlp3eXJ0QS0tSFhpVUFwU3o5YTJkUGZYaWFrUDRVbHRqN2ZvbXJfM2tCX1NhRU1ZM0Q3Z29hbTE2UjBRRTdxRC11bm5IRDNibUtxbWJPZVBhZVg5YWpESlAyYXdKQy1FeGVENkE5dU5LREFyNExDWExTLVRXZE52dw?oc=5","score":0.55,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"google_news_rss","published":"Fri, 02 Oct 2026 08:15:00 GMT","source_url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQUk40RWRJc3VxZ2xmVlR3YU4yY3VYdXZ2NXdBVmFJbl83bmVoSUl6V2RXVjJWSUJxWUVMczVvSFFqRGNOc29RU3dFdWN4ZFNxMjU4Wlp3eXJ0QS0tSFhpVUFwU3o5YTJkUGZYaWFrUDRVbHRqN2ZvbXJfM2tCX1NhRU1ZM0Q3Z29hbTE2UjBRRTdxRC11bm5IRDNibUtxbWJPZVBhZVg5YWpESlAyYXdKQy1FeGVENkE5dU5LREFyNExDWExTLVRXZE52dw?oc=5","retrieved_at":"2026-10-11T12:30:39Z","search_query":"\"suboxone\" (lawsuit OR settlement OR recall OR \"class action\")"},"resolved_by":"auto","resolution_confidence":0.875,"first_seen_iso":"2026-10-03T11:31:45Z","last_seen_iso":"2026-10-11T12:30:39Z","schema_version":1},{"signal_id":"sig_32f325e96709c7","matter_id":"mat_5c445c740078a1","source":"google_news","source_id":"gnews:CBMia0FVX3lxTE5kVjNKMzRLRVlMVC0zcnNCNjRXZlRONHhMRXR4NDE1dnd5SVV3VFpEYWdzNGQ5Xzd3RURKbGhScGxFQnQ4REJOU1NzbG5PNmtKTnhDeVhjazVYd3dSVVJTNUdYTDF6VzA3bndF","kind":"news_article","title":"Ban on Suboxone use for ‘safety-sensitive’ roles draws EEOC lawsuit - HR Dive","summary":"Ban on Suboxone use for ‘safety-sensitive’ roles draws EEOC lawsuit    HR Dive","url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE5kVjNKMzRLRVlMVC0zcnNCNjRXZlRONHhMRXR4NDE1dnd5SVV3VFpEYWdzNGQ5Xzd3RURKbGhScGxFQnQ4REJOU1NzbG5PNmtKTnhDeVhjazVYd3dSVVJTNUdYTDF6VzA3bndF?oc=5","score":0.55,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"google_news_rss","published":"Thu, 01 Oct 2026 07:00:00 GMT","source_url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE5kVjNKMzRLRVlMVC0zcnNCNjRXZlRONHhMRXR4NDE1dnd5SVV3VFpEYWdzNGQ5Xzd3RURKbGhScGxFQnQ4REJOU1NzbG5PNmtKTnhDeVhjazVYd3dSVVJTNUdYTDF6VzA3bndF?oc=5","retrieved_at":"2026-10-18T10:49:37Z","search_query":"\"suboxone\" (lawsuit OR settlement OR recall OR \"class action\")"},"resolved_by":"auto","resolution_confidence":0.875,"first_seen_iso":"2026-10-02T10:58:26Z","last_seen_iso":"2026-10-18T10:49:37Z","schema_version":1},{"signal_id":"sig_6da27f630a4ca2","matter_id":"mat_5c445c740078a1","source":"google_news","source_id":"gnews:CBMirAFBVV95cUxPWG44dENnZHg1OTl0TXFpV01KV3hUaXNwYzhKSUVGWmV1b2hTQXdUYWNFaG5PUThfSHJpVUR2YUZGczQ5QVJ0WkR6MTk0Z1cySDhwMnpIZEJKLTlvR1BjeTg3X3Vxb2ktNW94Uzd5ZktBcVZXaFBSOEpKRzZzQ0NwdWZTTGN5N203MkFOcFdJcDdscU9OeWFyeWNIdklvbGJJZFdJY2FzblhmRUVT","kind":"news_article","title":"Lawyers Preparing 35 Suboxone Tooth Decay Lawsuits in Core Discovery Pool - AboutLawsuits.com","summary":"Lawyers Preparing 35 Suboxone Tooth Decay Lawsuits in Core Discovery Pool    AboutLawsuits.com","url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPWG44dENnZHg1OTl0TXFpV01KV3hUaXNwYzhKSUVGWmV1b2hTQXdUYWNFaG5PUThfSHJpVUR2YUZGczQ5QVJ0WkR6MTk0Z1cySDhwMnpIZEJKLTlvR1BjeTg3X3Vxb2ktNW94Uzd5ZktBcVZXaFBSOEpKRzZzQ0NwdWZTTGN5N203MkFOcFdJcDdscU9OeWFyeWNIdklvbGJJZFdJY2FzblhmRUVT?oc=5","score":0.55,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"google_news_rss","published":"Wed, 30 Sep 2026 16:00:00 GMT","source_url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPWG44dENnZHg1OTl0TXFpV01KV3hUaXNwYzhKSUVGWmV1b2hTQXdUYWNFaG5PUThfSHJpVUR2YUZGczQ5QVJ0WkR6MTk0Z1cySDhwMnpIZEJKLTlvR1BjeTg3X3Vxb2ktNW94Uzd5ZktBcVZXaFBSOEpKRzZzQ0NwdWZTTGN5N203MkFOcFdJcDdscU9OeWFyeWNIdklvbGJJZFdJY2FzblhmRUVT?oc=5","retrieved_at":"2026-10-18T10:49:37Z","search_query":"\"suboxone\" (lawsuit OR settlement OR recall OR \"class action\")"},"resolved_by":"auto","resolution_confidence":0.925,"first_seen_iso":"2026-10-01T12:30:59Z","last_seen_iso":"2026-10-18T10:49:37Z","schema_version":1},{"signal_id":"sig_5b0c048cee1c4b","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:74699709","kind":"court_filing","title":"CL filing: Cooper v. Smith","summary":"Federal filing in wawd, docket 2:26-cv-02977, dated 2026-08-21.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"wawd","docket_no":"2:26-cv-02977","date_filed":"2026-08-21","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-10-18T10:58:15Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-30T12:13:51Z","last_seen_iso":"2026-10-18T10:58:15Z","schema_version":1},{"signal_id":"sig_6da3686e812c09","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:74716701","kind":"court_filing","title":"CL filing: Krueger v. Davis","summary":"Federal filing in mnd, docket 0:26-cv-03811, dated 2026-08-28.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"mnd","docket_no":"0:26-cv-03811","date_filed":"2026-08-28","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-10-18T10:58:15Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-30T12:13:51Z","last_seen_iso":"2026-10-18T10:58:15Z","schema_version":1},{"signal_id":"sig_d84f21dd078eb3","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:74833112","kind":"court_filing","title":"CL filing: United States v. All Funds on Deposit (approx. $111,674.44 in funds as of August 26, 2026) from Bank Account XXXXXX6590 held in the name of Quality Behavioral Health, Inc. at Citizens Bank","summary":"Federal filing in mied, docket 2:26-cv-13589, dated 2026-09-22.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"mied","docket_no":"2:26-cv-13589","date_filed":"2026-09-22","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-10-18T10:58:15Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-23T10:58:50Z","last_seen_iso":"2026-10-18T10:58:15Z","schema_version":1},{"signal_id":"sig_a5ba16c0ea854f","matter_id":"mat_5c445c740078a1","source":"regulations_gov","source_id":"reggov:FDA-2026-P-10331-0015","kind":"regulations_doc","title":"Reference 12","summary":"Background Material","url":"https://www.regulations.gov/document/FDA-2026-P-10331-0015","score":0.5,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Supporting & Related Material","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2026-P-10331-0015","posted_date":"2026-09-22T04:00:00Z","retrieved_at":"2026-10-18T10:50:48Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-23T10:51:25Z","last_seen_iso":"2026-10-18T10:50:48Z","schema_version":1},{"signal_id":"sig_a7878c3642c071","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:74804965","kind":"court_filing","title":"CL filing: United States v. Warrant","summary":"Federal filing in nmd, docket 1:26-mr-01746, dated 2026-08-20.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"nmd","docket_no":"1:26-mr-01746","date_filed":"2026-08-20","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-10-18T10:58:15Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-17T11:11:28Z","last_seen_iso":"2026-10-18T10:58:15Z","schema_version":1},{"signal_id":"sig_c000aa77ebd2f1","matter_id":"mat_5c445c740078a1","source":"regulations_gov","source_id":"reggov:FDA-2026-P-10693-0015","kind":"regulations_doc","title":"Exhibit 02 - DESCOVY Prescribing Information","summary":"Background Material","url":"https://www.regulations.gov/document/FDA-2026-P-10693-0015","score":0.5,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Supporting & Related Material","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2026-P-10693-0015","posted_date":"2026-09-15T04:00:00Z","retrieved_at":"2026-10-14T11:40:33Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-16T10:55:13Z","last_seen_iso":"2026-10-14T11:40:33Z","schema_version":1},{"signal_id":"sig_9e0587460f647d","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:73673562","kind":"court_filing","title":"CL filing: WINGHAM v. CENTURION HEALTH OF INDIANA, LLC","summary":"Federal filing in insd, docket 1:26-cv-01560, dated 2026-07-23.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"insd","docket_no":"1:26-cv-01560","date_filed":"2026-07-23","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-10-05T14:14:00Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-08T10:47:42Z","last_seen_iso":"2026-10-05T14:14:00Z","schema_version":1},{"signal_id":"sig_4cd3e5a753c950","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:73720875","kind":"court_filing","title":"CL filing: United States v. Morris","summary":"Federal filing in kywd, docket 3:26-cr-00090, dated 2026-07-22.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"kywd","docket_no":"3:26-cr-00090","date_filed":"2026-07-22","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-10-02T13:08:45Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-09-04T10:48:43Z","last_seen_iso":"2026-10-02T13:08:45Z","schema_version":1},{"signal_id":"sig_94607304e10dfa","matter_id":"mat_5c445c740078a1","source":"courtlistener_search","source_id":"cl-search:74716150","kind":"court_filing","title":"CL filing: FUSSELL v. CORECARE BEHAVIORAL HEALTH MANAGEMENT, INC.","summary":"Federal filing in paed, docket 2:26-cv-06420, dated 2026-08-28.","url":"https://www.courtlistener.com/recap/?q=suboxone","score":0.75,"decayed_score":null,"keywords":{"brands":[],"products":[]},"provenance":{"feed":"courtlistener_v4_search","court":"paed","docket_no":"2:26-cv-06420","date_filed":"2026-08-28","source_url":"https://www.courtlistener.com/recap/?q=suboxone","retrieved_at":"2026-10-18T10:58:15Z","search_query":"suboxone"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-28T18:24:10Z","last_seen_iso":"2026-10-18T10:58:15Z","schema_version":1},{"signal_id":"sig_6b19fd27740c3a","matter_id":"mat_5c445c740078a1","source":"regulations_gov","source_id":"reggov:FDA-2026-P-9803-0008","kind":"regulations_doc","title":"Reference 6","summary":"Background Material","url":"https://www.regulations.gov/document/FDA-2026-P-9803-0008","score":0.5,"decayed_score":null,"keywords":{"brands":["indivior","reckitt benckiser"],"products":["suboxone","buprenorphine","naloxone","sublingual film"]},"provenance":{"feed":"regulations_gov_v4","doc_type":"Supporting & Related Material","file_url":null,"agency_id":"FDA","source_url":"https://www.regulations.gov/document/FDA-2026-P-9803-0008","posted_date":"2026-08-26T04:00:00Z","retrieved_at":"2026-10-06T13:11:31Z"},"resolved_by":"search_context","resolution_confidence":0.3,"first_seen_iso":"2026-08-27T17:22:58Z","last_seen_iso":"2026-10-06T13:11:31Z","schema_version":1}]},"meta":{"api_version":"v1","schema_version":1,"self":"https://getclaimscout.com/api/v1/matters/suboxone-tooth-decay","docs":"https://getclaimscout.com/openapi.json","llms_txt":"https://getclaimscout.com/llms.txt"}}